Literature DB >> 19540364

Peptidylarginine deiminase 4 and citrullination in health and disease.

Consuelo Anzilotti1, Federico Pratesi, Cristina Tommasi, Paola Migliorini.   

Abstract

Deimination is catalyzed by a family of calcium binding enzymes, called peptidylarginine deiminases (PADs). Among these, the PAD4 isoform has been more extensively studied for its role in some autoimmune diseases. PAD4 is localized in the cytoplasm of monocytes, T and B cells, neutrophils, eosinophils and NK cells and can move to the nucleus upon cell activation. PAD4 plays a physiological role in gene regulation via citrullination of histones. In rheumatoid arthritis (RA), PAD4 contributes to the generation of ACPA specific substrates and is itself a target of autoantibodies; alleles of the PADI4 gene confer susceptibility to RA in Asians but not in Caucasians. In multiple sclerosis, extensive deimination of brain proteins is observed in active lesions, but no role for the PADI4 gene in susceptibility to MS has been so far described. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540364     DOI: 10.1016/j.autrev.2009.06.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  59 in total

Review 1.  The redox basis of epigenetic modifications: from mechanisms to functional consequences.

Authors:  Anthony R Cyr; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2011-02-05       Impact factor: 8.401

Review 2.  Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality.

Authors:  Q Remijsen; T W Kuijpers; E Wirawan; S Lippens; P Vandenabeele; T Vanden Berghe
Journal:  Cell Death Differ       Date:  2011-02-04       Impact factor: 15.828

Review 3.  A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens.

Authors:  Hannah Tomlin; Anna M Piccinini
Journal:  Immunology       Date:  2018-07-05       Impact factor: 7.397

Review 4.  The autoimmune side of heart and lung diseases.

Authors:  Nancy Agmon-Levin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 5.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

6.  Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO.

Authors:  May M Rabadi; Sang Jun Han; Mihwa Kim; Vivette D'Agati; H Thomas Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-03

7.  Inhibition of peptidylarginine deiminase attenuates inflammation and improves survival in a rat model of hemorrhagic shock.

Authors:  Wei He; Peter Zhou; Zhigang Chang; Baoling Liu; Xuefeng Liu; Yanming Wang; Yongqing Li; Hasan B Alam
Journal:  J Surg Res       Date:  2015-09-09       Impact factor: 2.192

8.  Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis.

Authors:  Ruchi Yadav; Dae-Goon Yoo; J Michelle Kahlenberg; S Louis Bridges; Oluwadamilola Oni; Hanwen Huang; Arlene Stecenko; Balázs Rada
Journal:  J Cyst Fibros       Date:  2019-01-10       Impact factor: 5.482

9.  Great Therapeutic Potential of Peptidylarginine Deiminase 4 (PAD4) Inhibitors: Treatment of Rheumatoid Arthritis, Epigenetic Tools, Regulation of Pluripotency in Stem Cells, and More.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2016-12-30       Impact factor: 4.345

10.  PADI4 and tumourigenesis.

Authors:  Xiaotian Chang; Kehua Fang
Journal:  Cancer Cell Int       Date:  2010-03-12       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.